Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 29 checked references that resolve
resolves10.1359/jbmr.1997.12.1.24Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis Foundation
resolves10.1007/s001980050010Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis
resolves10.1001/jama.282.7.637Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
resolves10.1016/S8756-3282(00)00376-8Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women
resolves10.1172/JCI119668Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis.
resolves10.1056/NEJM200105103441904Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
resolves10.1016/S8756-3282(01)00484-7Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis)
resolves10.1002/jbmr.5650080512An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats
resolves10.1002/jbmr.5650110915Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration
resolves10.1210/jc.87.5.2060Strontium Ranelate: Dose-Dependent Effects in Established Postmenopausal Vertebral Osteoporosis--A 2-Year Randomized Placebo Controlled Trial
resolves10.1002/jbmr.5650110716Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis
resolves10.1007/BF01622258Comparison of semiquantitative and quantitative techniques for the assessment of prevalent and incident vertebral fractures
resolves10.1385/JCD:2:1:37The Use of Different Dual X-Ray Absorptiometry Brands in a Multicenter Clinical Trial
resolves10.1007/s001980070007Markers of Bone Turnover for Monitoring Treatment of Osteoporosis with Antiresorptive Drugs
resolves10.1016/S0140-6736(97)02342-8Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis
resolves10.1056/NEJMoa031975The Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal Osteoporosis
resolves10.1016/S1094-6950(06)60402-2Influence of Strontium on Bone Mineral Density and Bone Mineral Content Measurements by Dual X-Ray Absorptiometry
resolves10.1007/s001980200129Prevention of Early Postmenopausal Bone Loss by Strontium Ranelate: The Randomized, Two-Year, Double-Masked, Dose-Ranging, Placebo-Controlled PREVOS Trial
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.